A Phase 1 Study to Evaluate the Potential Drug Interactions Between Repotrectinib and Metformin, Digoxin, and Rosuvastatin in Patients With Advanced Solid Tumors

Name: A Phase 1 Study to Evaluate the Potential Drug Interactions Between Repotrectinib and Metformin, Digoxin, and Rosuvastatin in Patients With Advanced Solid Tumors
License: Public Domain

Turning Point Therapeutics, Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

advanced solid tumor, metastatic solid tumor

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 230374
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.